# Marimed Inc.: filings

MRMD · OTC · CIK 1522767 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mrmd.md) · [Financials](/companies/mrmd/financials.md) · [Filings](/companies/mrmd/filings.md) · [Insiders](/companies/mrmd/insiders.md)

## Reports and events: 147 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 168, 8-K 73, 10-Q 46, 10-K 15, 3 15, UPLOAD 9, DEF 14A 8, NT 10-K 7, NT 10-Q 6, 10-12G/A 5, ARS 4, CORRESP 4, 10-Q/A 3, 10-K/A 2, PRE 14A 2, S-8 2, 10-12G 1, 3/A 1, 424B3 1, DEF 14C 1, EFFECT 1, PRE 14C 1, S-3 1, SC 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:13 ET | [8-K](/filings/0001522767-26-000213.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001522767-26-000213 |
| 2026-09-23 | 16:05 ET | [8-K](/filings/0001522767-26-000188.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001522767-26-000188 |
| 2026-09-22 | 16:42 ET | [DEF 14A](/filings/0001522767-26-000183.md) | Proxy statement, period 2026-10-28 | 0001522767-26-000183 |
| 2026-08-13 | 16:11 ET | [10-Q](/filings/0001522767-26-000167.md) | Quarterly report, period 2026-06-30 | 0001522767-26-000167 |
| 2026-08-12 | 17:07 ET | [8-K](/filings/0001522767-26-000164.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001522767-26-000164 |
| 2026-06-08 | 16:18 ET | [8-K](/filings/0001522767-26-000107.md) | 5.07 Shareholder vote results | 0001522767-26-000107 |
| 2026-05-14 | 16:19 ET | [10-Q](/filings/0001522767-26-000073.md) | Quarterly report, period 2026-03-31 | 0001522767-26-000073 |
| 2026-05-13 | 17:13 ET | [8-K](/filings/0001522767-26-000070.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001522767-26-000070 |
| 2026-04-23 | 16:06 ET | [DEF 14A](/filings/0001522767-26-000058.md) | Proxy statement, period 2026-06-04 | 0001522767-26-000058 |
| 2026-03-12 | 16:08 ET | [10-K](/filings/0001522767-26-000030.md) | Annual report, period 2025-12-31 | 0001522767-26-000030 |
| 2026-03-11 | 17:07 ET | [8-K](/filings/0001522767-26-000027.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001522767-26-000027 |
| 2026-03-02 | 16:03 ET | [8-K](/filings/0001522767-26-000011.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001522767-26-000011 |
| 2025-11-06 | 16:06 ET | [10-Q](/filings/0001522767-25-000224.md) | Quarterly report, period 2025-09-30 | 0001522767-25-000224 |
| 2025-11-05 | 17:04 ET | [8-K](/filings/0001522767-25-000222.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001522767-25-000222 |
| 2025-08-07 | 16:12 ET | [10-Q](/filings/0001522767-25-000169.md) | Quarterly report, period 2025-06-30 | 0001522767-25-000169 |
| 2025-08-06 | 17:10 ET | [8-K](/filings/0001522767-25-000167.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001522767-25-000167 |
| 2025-06-13 | 16:23 ET | [8-K](/filings/0001522767-25-000130.md) | 5.07 Shareholder vote results | 0001522767-25-000130 |
| 2025-05-08 | 16:36 ET | [10-Q](/filings/0001522767-25-000052.md) | Quarterly report, period 2025-03-31 | 0001522767-25-000052 |
| 2025-05-07 | 17:05 ET | [8-K](/filings/0001522767-25-000048.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001522767-25-000048 |
| 2025-04-30 | 16:04 ET | [DEF 14A](/filings/0001522767-25-000041.md) | Proxy statement, period 2025-06-12 | 0001522767-25-000041 |
| 2025-03-06 | 17:05 ET | [10-K](/filings/0001522767-25-000014.md) | Annual report, period 2024-12-31 | 0001522767-25-000014 |
| 2025-03-05 | 17:12 ET | [8-K](/filings/0001522767-25-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001522767-25-000010 |
| 2024-11-07 | 17:05 ET | [10-Q](/filings/0001522767-24-000091.md) | Quarterly report, period 2024-09-30 | 0001522767-24-000091 |
| 2024-11-06 | 17:05 ET | [8-K](/filings/0001522767-24-000088.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001522767-24-000088 |
| 2024-08-09 | 17:04 ET | [8-K](/filings/0001522767-24-000069.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001522767-24-000069 |
| 2024-08-08 | 17:23 ET | [10-Q](/filings/0001522767-24-000065.md) | Quarterly report, period 2024-06-30 | 0001522767-24-000065 |
| 2024-08-07 | 17:06 ET | [8-K](/filings/0001522767-24-000063.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001522767-24-000063 |
| 2024-06-06 | 17:07 ET | [8-K](/filings/0001522767-24-000045.md) | 5.07 Shareholder vote results | 0001522767-24-000045 |
| 2024-05-09 | 11:38 ET | [10-Q](/filings/0001522767-24-000042.md) | Quarterly report, period 2024-03-31 | 0001522767-24-000042 |
| 2024-05-08 | 17:10 ET | [8-K](/filings/0001522767-24-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001522767-24-000040 |
| 2024-04-29 | 16:10 ET | [DEF 14A](/filings/0001522767-24-000027.md) | Proxy statement, period 2024-04-29 | 0001522767-24-000027 |
| 2024-03-07 | 16:02 ET | [10-K](/filings/0001522767-24-000007.md) | Annual report, period 2023-12-31 | 0001522767-24-000007 |
| 2024-03-06 | 17:06 ET | [8-K](/filings/0001522767-24-000005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001522767-24-000005 |
| 2023-11-20 | 17:03 ET | [8-K](/filings/0001522767-23-000129.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001522767-23-000129 |
| 2023-11-09 | 16:07 ET | [10-Q](/filings/0001522767-23-000123.md) | Quarterly report, period 2023-09-30 | 0001522767-23-000123 |
| 2023-11-08 | 17:06 ET | [8-K](/filings/0001522767-23-000119.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001522767-23-000119 |
| 2023-11-03 | 07:35 ET | [8-K](/filings/0001522767-23-000115.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001522767-23-000115 |
| 2023-08-04 | 14:45 ET | [10-Q](/filings/0001522767-23-000105.md) | Quarterly report, period 2023-06-30 | 0001522767-23-000105 |
| 2023-08-02 | 17:13 ET | [8-K](/filings/0001522767-23-000100.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001522767-23-000100 |
| 2023-06-12 | 17:10 ET | [8-K](/filings/0001522767-23-000095.md) | 5.07 Shareholder vote results | 0001522767-23-000095 |
| 2023-05-09 | 16:22 ET | [10-Q](/filings/0001522767-23-000079.md) | Quarterly report, period 2023-03-31 | 0001522767-23-000079 |
| 2023-05-08 | 17:03 ET | [8-K](/filings/0001522767-23-000075.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001522767-23-000075 |
| 2023-04-27 | 17:04 ET | [DEF 14A](/filings/0001522767-23-000053.md) | Proxy statement, period 2023-06-08 | 0001522767-23-000053 |
| 2023-04-17 | 17:18 ET | [8-K](/filings/0001522767-23-000045.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001522767-23-000045 |
| 2023-03-06 | 16:20 ET | [10-K/A](/filings/0001522767-23-000025.md) | Annual report, amended, period 2022-12-31 | 0001522767-23-000025 |
| 2023-03-06 | 16:13 ET | [8-K](/filings/0001522767-23-000023.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001522767-23-000023 |
| 2023-03-03 | 15:08 ET | [10-K](/filings/0001522767-23-000015.md) | Annual report, period 2022-12-31 | 0001522767-23-000015 |
| 2023-03-01 | 17:15 ET | [8-K](/filings/0001522767-23-000009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001522767-23-000009 |
| 2023-01-24 | 17:04 ET | [8-K](/filings/0001522767-23-000004.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001522767-23-000004 |
| 2022-12-14 | 16:31 ET | [8-K](/filings/0001522767-22-000023.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001522767-22-000023 |

Page 1 of 3. [Older](/companies/mrmd/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:14 ET. No prices; not investment advice.